Frontlight ResearchEarly access
Taking people in United StatesNo phase
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Key facts
- Who runs it
- InSightec
- Where
- Los Angeles, Rochester, and Stanford, United StatesSee the 3 sitesAlso in 1 other country, 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 16 Feb 2016
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- Body System - Functional
- Record updated
- 30 April 2025
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
Also in 1 other country, 2 sites
- UCLALos Angeles, United StatesContact: Polly Kay, RN, CCRPTaking people
- Mayo ClinicRochester, United StatesContact: Brittany YaklichTaking people
- Stanford UniversityStanford, United StatesContact: Caroline HuangTaking people
About the trial
What the trial wants to find out
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
The group in the trial
- Exablate
Observational study of Exablate treatment.
Treatment: Body System - Functional
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Fit questions
- Built from NCT05386615, who can take part
- Record updated
- 30 April 2025